Table 5 General stroke versus NeurocovBR stroke
From: Neurological syndromes associated with COVID-19: a multicenter study in Brazil
| Â | General Stroke 11 | NeurocovBR Stroke | p | OR |
|---|---|---|---|---|
n, (%) | 2407 (100) | 81 (100) | Â | Â |
Age, mean (± SD) | 67.6 (± 14.4) | 59.5 (± 15.5) |  < 0.01 | _ |
Female, n (%) | 1248 (51.8) | 46 (56.8) | 0.46 | _ |
Comorbidities, n (%) | ||||
 HBP | 2118 (88) | 45 (51.1) |  < 0.01 | 0.17 |
 DM | 1126 (46.8) | 28 (31.8) |  < 0.05 | 0.60 |
 Smoker | 736 (30.6) | 15 (17) |  < 0.05 | 0.51 |
Hospitalization, n, (%) | ||||
 Needed ICU | 597 (24.8) | 46 (56.8) |  < 0.01 | 3.78 |
 Δt hospitalization, d, mean (± SD) | 15.4 (± 20.1) | 18.7 (± 23) | 0.20 | _ |
In-hospital complications, n, (%) | ||||
 Co-infections | 424 (17.6) | 55 (67.9) |  < 0.01 | 6.14 |
Outcomes | ||||
 Death, n, (%) | 503 (20.9) | 45 (55.6) |  < 0.01 | 4.73 |